Trinity Biotech | TRIB - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Bayer EUR 4.29B 1.44B 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
EDAP TMS EUR 15.01M 14.82M 2026-03
J&J USD 20.42B 1.27B 2026-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
OraSure Technologies USD 160.58M 16.38M 2026-06
Plus Therapeutics USD 2.37M 656K 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 8.66B 6.6B 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tosoh JPY 179.62B 46.51B 2026-03
Trinity Biotech USD 5.14M 3.8M 2025-12
Veracyte USD 299.52M 36.38M 2026-06